Department of Radiology, University Hospital Basel, Basel, Switzerland.
Center for Neuroendocrine and Endocrine Tumors, University Hospital Basel, Basel, Switzerland.
PLoS One. 2021 Jun 11;16(6):e0253078. doi: 10.1371/journal.pone.0253078. eCollection 2021.
Pancreatic islet-cell tumors (PICT) often present with atypical signal-characteristics and are often missed on preoperative imaging. The aim of this study is to provide a multiparametric PICT characterization and investigate factors impeding PICT detection.
This is a detailed MRI analysis of a prospective, monocenter study, including 49 consecutive patients (37 female, 12 male; median age 50) with symptoms due to endogenous hyperinsulinemic hypoglycemia (EHH) and mostly negative prior-imaging. All patients received a 3-T MRI and a 68Ga-DOTA-exendin-4-PET/CT. Pooled accuracy, sensitivity, specificity and inter-reader agreement were calculated. Reference-standard was histopathology and 68Ga-DOTA-Exendin-4-PET/CT in one patient who refused surgery. For PICT analyses, 34 patients with 49 PICTs (48 histologically proven; one 68Ga-DOTA-exendin-4-PET/CT positive) were assessed. Dynamic contrast-enhanced (DCE) Magnetic Resonance Images (MRI) with Golden-Angle-Radial-Sparse-Parallel (GRASP) reconstruction, enabling imaging at high spatial and temporal resolution, was used to assess enhancement-patterns of PICTs. Tumor-to-background (T2B) ratio for each sequence and the employed quantitative threshold for conspicuity of PICTs were analyzed in regard to prediction of true-positive PICTs.
Evaluation of 49 patients revealed a pooled lesion-based accuracy, sensitivity and specificity of 70.3%, 72.9% and 62.5%, respectively. Mean PICT size was 12.9±5.3mm for detected, 9.0±2.9mm for undetected PICTs (p-value 0.0112). In-phase T1w detected the most PICT (67.3%). Depending on the sequence, PICTs were isointense and poorly visible in 29-68%. Only 2/41(4.9%) PICTs showed typical signal-characteristics across T1w, T2w, DWI and ceT1w combined. 66.6% of PICTs enhanced simultaneously to the parenchyma, 17.8% early and 15.6% late. Predictor screening analysis showed number of sequences detecting a PICT, lesion size and in-phase T1w T2B ratio had the highest contribution for detecting a true-positive PICT.
The majority of PICTs enhance simultaneously to surrounding parenchyma, present with atypical signal-characteristics and thus are poorly visible. In non-enhancing PICTs, radiologists should search for small lesions most likely conspicuous on unenhanced T1w or DWI.
胰腺胰岛细胞瘤(PICT)常表现出非典型的信号特征,术前影像学检查常漏诊。本研究旨在提供胰腺胰岛细胞瘤的多参数特征分析,并探讨阻碍胰腺胰岛细胞瘤检测的因素。
这是一项前瞻性单中心研究的详细 MRI 分析,共纳入 49 例连续患者(37 例女性,12 例男性;中位年龄 50 岁),因内源性高胰岛素血症性低血糖(EHH)出现症状,且大部分患者术前影像学检查均为阴性。所有患者均接受 3T MRI 和 68Ga-DOTA-exendin-4-PET/CT 检查。计算了汇总准确性、敏感度、特异度和读者间一致性。以组织病理学和 1 例拒绝手术的患者的 68Ga-DOTA-exendin-4-PET/CT 为参考标准。对 34 例 49 个 PICT(48 个经组织学证实;1 个 68Ga-DOTA-exendin-4-PET/CT 阳性)患者进行 PICT 分析。使用 Golden-Angle-Radial-Sparse-Parallel(GRASP)重建的动态对比增强(DCE)磁共振成像(MRI),可实现高空间和时间分辨率成像,用于评估 PICT 的增强模式。分析了每个序列的肿瘤与背景(T2B)比值和用于检测 PICT 显著性的定量阈值,以预测真正的阳性 PICT。
对 49 例患者的评估显示,基于病变的汇总准确性、敏感度和特异度分别为 70.3%、72.9%和 62.5%。检测到的 PICT 的平均大小为 12.9±5.3mm,未检测到的 PICT 大小为 9.0±2.9mm(p 值=0.0112)。同相位 T1w 检测到的 PICT 最多(67.3%)。根据序列的不同,29%-68%的 PICT 呈等信号,且难以识别。仅 2/41(4.9%)个 PICT 联合 T1w、T2w、DWI 和 ceT1w 显示出典型的信号特征。66.6%的 PICT 与周围实质同时增强,17.8%早期增强,15.6%晚期增强。预测因子筛查分析显示,检测到 PICT 的序列数量、病变大小和同相位 T1w T2B 比值对检测真正的阳性 PICT 有最高的贡献。
大多数 PICT 与周围实质同时增强,表现出非典型的信号特征,因此难以识别。在无强化的 PICT 中,放射科医生应在未增强的 T1w 或 DWI 上寻找最有可能明显显示的小病变。